Show Summary Details
Page of

Therapy-related issues: malignant diseases and immunosuppression 

Therapy-related issues: malignant diseases and immunosuppression
Therapy-related issues: malignant diseases and immunosuppression

Philip Wiffen

, Marc Mitchell

, Melanie Snelling

, and Nicola Stoner

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 October 2021

This chapter outlines information relevant to clinical pharmacists related to malignant disease and immunosuppression and is loosely based on the British National Formulary, Chapter 8. In particular, this chapter covers administration and handling of cytotoxic drugs, clinical screening of chemotherapy prescriptions, chemotherapy dosing and toxicity, antiemetics for chemotherapy-induced nausea and vomiting, extravasation, and intrathecal administration of chemotherapy.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.